Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib cream plus phototherapy for non-segmental vitiligo (real-world, China)
ChiCTR2600127689Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Southwest Medical University
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ruxolitinib in Vitiligo, sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoint: F-VASI 75 at Week 24. Started Jul 2026; status: recruiting.
02
Drugs
03
Conditions
Vitiligo
Beyond the preview
Go deeper on ChiCTR2600127689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127689.